首页> 美国卫生研究院文献>other >Tunable Staged Release of Therapeutics from Layer-by-Layer Coatings with Clay Interlayer Barrier
【2h】

Tunable Staged Release of Therapeutics from Layer-by-Layer Coatings with Clay Interlayer Barrier

机译:从具有粘土夹层屏障的多层涂层中逐步分阶段释放治疗药物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In developing new generations of coatings for medical devices and tissue engineering scaffolds, there is a need for thin coatings that provide controlled sequential release of multiple therapeutics while providing a tunable approach to time dependence and the potential for sequential or staged release. Herein, we demonstrate the ability to develop a self-assembled, polymer-based conformal coating, built by using a water-based layer-by-layer (LbL) approach, as a dual-purpose biomimetic implant surface that provides staggered and/or sustained release of an antibiotic followed by active growth factor for orthopedic implant applications. This multilayered coating consists of two parts: a base osteoinductive component containing bone morphogenetic protein-2 (rhBMP-2) beneath an antibacterial component containing gentamicin (GS). For the fabrication of truly stratified composite films with the customized release behavior, we present a new strategy—implementation of laponite clay barriers—that allows for a physical separation of the two components by controlling interlayer diffusion. The clay barriers in a single-component GS system effectively block diffusion-based release, leading to approximately 50% reduction in bolus doses and 10-fold increase in the release timescale. In a dual-therapeutic composite coating, the top GS component itself was found to be an effective physical barrier for the underlying rhBMP-2, leading to an order of magnitude increase in the release timescale compared to the single-component rhBMP-2 system. The introduction of a laponite interlayer barrier further enhanced the temporal separation between release of the two drugs, resulting in a more physiologically appropriate dosing of rhBMP-2. Both therapeutics released from the composite coating retained their efficacy over their established release timeframes. This new platform for multi-drug localized delivery can be easily fabricated, tuned, and translated to a variety of implant applications where control over spatial and temporal release profiles of multiple drugs is desired.
机译:在开发用于医疗设备和组织工程支架的新一代涂层时,需要薄涂层,其提供多种治疗剂的受控顺序释放,同时提供对时间依赖性的可调方法以及顺序或分阶段释放的潜力。在本文中,我们展示了开发自组装的,基于聚合物的保形涂层的能力,该涂层是通过使用水基逐层(LbL)方法构建的,可提供交错和/或交错的两用仿生植入物表面在整形外科植入应用中持续释放抗生素,然后释放活性生长因子。该多层涂层由两部分组成:含有骨形态发生蛋白2(rhBMP-2)的基础骨诱导成分,其中含有庆大霉素(GS)的抗菌成分。为了制造具有定制释放性能的真正分层复合薄膜,我们提出了一种新策略-合成锂皂石粘土屏障-通过控制层间扩散实现两种组分的物理分离。单组分GS系统中的粘土屏障有效地阻止了基于扩散的释放,从而使大剂量剂量减少了约50%,释放时间范围增加了10倍。在双重治疗复合涂层中,发现顶部GS成分本身是对下层rhBMP-2的有效物理屏障,与单成分rhBMP-2系统相比,释放时间尺度增加了一个数量级。皂石层间阻隔层的引入进一步增强了两种药物释放之间的时间间隔,从而使rhBMP-2在生理上更合适。从复合涂层释放的两种治疗剂均在其确定的释放时间范围内保持其功效。这种用于多药局部递送的新平台可以轻松地制造,调整和转换为需要控制多种药物的时空释放曲线的各种植入应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号